Cleared Traditional

K864449 - DIGOXIN/RIA KIT COATED TUBE RADIOIMMUNOASSAY KIT

K864449 is an FDA 510(k) clearance for DIGOXIN/RIA KIT COATED TUBE RADIOIMMUNO..., manufactured by Canadian Bioclinical, Ltd.. The device is a Class 2 Chemistry device with product code DPO cleared through the Traditional 510(k) pathway after a 82-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1987
Decision
82d
Days
Class 2
Risk

K864449 is an FDA 510(k) clearance for the DIGOXIN/RIA KIT COATED TUBE RADIOIMMUNOASSAY KIT. Classified as Radioimmunoassay, Digoxin (125-i), Rabbit Antibody, Coated Tube Sep. (product code DPO), Class II - Special Controls.

Submitted by Canadian Bioclinical, Ltd. (Ontario Mix 1b4, CA). The FDA issued a Cleared decision on February 2, 1987 after a review of 82 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.3320 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K864449

510(k) Number K864449 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 12, 1986
Decision Date February 02, 1987
Days to Decision 82 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
7d faster than avg
Panel avg: 89d · This submission: 82d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DPO Device Classification - Class 2, Special Controls

Product Code DPO Radioimmunoassay, Digoxin (125-i), Rabbit Antibody, Coated Tube Sep.
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - DPO Radioimmunoassay, Digoxin (125-i), Rabbit Antibody, Coated Tube Sep.

All 13
Devices cleared under the same product code (DPO) and FDA review panel - the closest regulatory comparables to K864449.
IMMULITE DIGOXIN
K914833 · Cirrus Diagnostics, Inc. · Nov 1991
ECLIPSE ICA DIGOXIN
K905719 · Biotope, Inc. · Jan 1991
RIA COAT DIGOXIN
K833842 · Immuno Assay Corp. · Jan 1984
SOPHEIA DIGOXIN EIA KIT
K832163 · Diagnostic Products Corp. · Aug 1983
IMMUCHEM COVALENT-COAT RIA KIT
K830962 · Immuchem Corp. · May 1983
COAT-A-COUNT DIGOXIN RIA
K811932 · Diagnostic Products Corp. · Jul 1981